Topics

U.S. FDA flags probable cancer-causing impurity in common heartburn drugs

06:41 EDT 13 Sep 2019 | Reuters

The U.S. Food and Drug Administration said on Friday that some medicines containing ranitidine, including Sanofi SA's Zantac, had traces of a probable cancer-causing impurity called N-nitrosodimethylamine (NDMA) at low levels.

Original Article: U.S. FDA flags probable cancer-causing impurity in common heartburn drugs

NEXT ARTICLE

More From BioPortfolio on "U.S. FDA flags probable cancer-causing impurity in common heartburn drugs"

Quick Search

Relevant Topics

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...